Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in The Netherlands

被引:195
作者
van Soolingen, D
de Haas, PEW
van Doorn, HR
Kuijper, E
Rinder, H
Borgdorff, MW
机构
[1] Natl Inst Publ Hlth & Environm, Diagnostic Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands
[2] Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands
[3] Univ Amsterdam, Amsterdam, Netherlands
[4] Royal Netherlands Tuberculosis Assoc, The Hague, Netherlands
[5] Univ Munich, Dept Trop Med & Infect Dis, Munich, Germany
关键词
D O I
10.1086/317598
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The prevalence of mutations at amino acid (aa) position 315 in the katG gene of isoniazid (INH)-resistant Mycobacterium tuberculosis isolates in The Netherlands and the mutation's association with the level of INH resistance, multidrug resistance, and transmission were determined. Of 4288 M. tuberculosis isolates with available laboratory results, 295 (7%) exhibited INH resistance. Of 148 aa 315 mutants, 89% had MICs of 5-10 mug/mL, whereas 75% of the other 130 INH-resistant strains had MICs of 0.5-1 mug/mL. Of the aa 315 mutants, 33% exhibited monodrug resistance, compared with 69% of other LNH-resistant strains (P < .0001), Multidrug resistance was found among 14% of the aa 315 mutants and 7% of the other INH-resistant strains (P > .05), The probability of being in an IS6110 DNA restriction fragment length polymorphism cluster was similar for aa 315 mutants and INH-susceptible strains, but the probability was reduced in other INH-resistant strains. Thus, aa 315 mutants lead to secondary cases of tuberculosis as often as INH-susceptible strains do.
引用
收藏
页码:1788 / 1790
页数:3
相关论文
共 17 条
  • [1] Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework
    Blower, SM
    Gerberding, JL
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (09): : 624 - 636
  • [2] COHN ML, 1954, AM REV TUBERC PULM, V70, P641
  • [3] Dobner P, 1997, INT J TUBERC LUNG D, V1, P365
  • [4] Outcome of multi-drug-resistant tuberculosis in France - A nationwide case-control study
    Flament-Saillour, M
    Robert, J
    Jarlier, V
    Grosset, J
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) : 587 - 593
  • [5] Gangadharam P.R.J., 1984, DRUG RESISTANCE MYCO
  • [6] Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa
    Haas, WH
    Schilke, K
    Brand, J
    Amthor, B
    Weyer, K
    Fourie, PB
    Bretzel, G
    StichtGroh, V
    Bremer, HJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1601 - 1603
  • [7] *HARV MED SCH OP S, 1999, GLOB IMP DRUGR TUB
  • [8] Multidrug resistance in Mycobacterium tuberculosis
    Heym, B
    Cole, ST
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1997, 8 (01) : 61 - 70
  • [9] Lambregts-van Weezenbeek CSB, 1998, INT J TUBERC LUNG D, V2, P296
  • [10] Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs
    Li, ZM
    Kelley, C
    Collins, F
    Rouse, D
    Morris, S
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) : 1030 - 1035